会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • VERFAHREN ZUR BESTIMMUNG VON VITELLOGENIN ALS BIOMARKER FÜR EINE EXOGENE ÖSTROGENE WIRKUNG AUF FISCHE
    • 用于确定卵黄蛋白原作为对鱼类外源性雌激素样作用的生物标志物
    • WO2015172756A1
    • 2015-11-19
    • PCT/DE2014/100161
    • 2014-05-10
    • GOBIO GMBHTECO MEDICAL AG
    • ALLNER, BernhardHENNIES, Mark
    • G01N33/68
    • G01N33/743G01N1/286G01N2333/4603
    • Aufgabe des offenbarten erfinderische Verfahren zur Bestimmung von Vitellogenin als Biomarker bzw. Endpunkt für eine exogene Östrogene Wirkung auf Fische ist es, ein nicht-destruktives Verfahren zu schaffen, bei welchem die Versuchstiere nicht getötet werden müssen. Das Verfahren soll hierbei auch keinen zusätzlichen Verbrauch von Versuchstieren zur Durchführung von Tests auf Östrogene, antiöstrogene und endokrine Disruptoren erfordern. Gelöst wird dies durch ein Verfahren zur Bestimmung von Vitellogenin als Biomarker für eine exogene Östrogene Wirkung auf Fische mit den Verfahrensschritten der Abnahme einer Hautschleimprobe eines Fisches durch Abstreichen, der Überführung der Hautschleimprobe in ein Reaktionsgefäß, Homogenisieren der Hautschleimprobe und der Entnahme eines Aliquots der Hautschleimprobe zur Vitellogeninbestimmung mittels eines ELISA Nachweisverfahrens.
    • 为卵黄蛋白原作为生物标志物或端点对鱼的外源性雌激素效应的确定所公开的本发明的方法的目的在于,提供一种非破坏性的方法,其中所述动物不需要被杀死。 这一过程应此要求的试验动物,用于对雌激素,抗雌激素和内分泌干扰物的测试没有额外的消费。 这是通过为卵黄蛋白原的确定作为对鱼类的外源性雌激素效果的生物标记物的方法来实现,通过刮擦,皮肤粘液样品的转移在一个反应​​容器中,均化皮肤粘液样品和对皮肤粘液样品的等分试样的提取包括鱼的皮肤粘液样品的减少的步骤 通过ELISA检测法Vitellogeninbestimmung。
    • 2. 发明申请
    • RAPID-THROUGHPUT TELEOST REGENERATION ASSAY
    • 快速通过电力再生测定
    • WO2008021168A3
    • 2008-09-25
    • PCT/US2007017697
    • 2007-08-07
    • OREGON STATETANGUAY ROBERT LMATHEW LIJOY K
    • TANGUAY ROBERT LMATHEW LIJOY K
    • A01N1/00A01N43/04C12N5/00
    • G01N33/5085G01N2333/4603
    • The present invention provides a method of simultaneously screening at least two candidate agents for an activity affecting regeneration of an embryonic teleost. According to this method, for each agent, a fin of the embryonic teleost is amputated. Next, the amputated teleost is incubated with the candidate agent for a specified period of time. After this period of time, the amputated teloeost is imaged. This image is compared to an image of an amputated teleost that was incubated for the specified period of time in the absence of the candidate agent. When comparing the images, a change in morphology of the amputated fin of the embryonic teleost incubated in the presence of the candidate agent compared to the amputated fin of the embryonic teleost raised in the absence of the candidate agent indicates that the candidate agent affects regeneration.
    • 本发明提供了一种同时筛选至少两种候选试剂以用于影响胚胎硬骨鱼的再生的活性的方法。 根据这种方法,对于每个试剂,切断胚胎硬骨鱼的鳍。 接下来,将截肢的硬骨鱼与候选药物孵育一段指定的时间。 经过这段时间后,被截肢的二聚体成像。 将该图像与在没有候选药剂的情况下孵育指定的时间段的截肢硬骨肉瘤的图像进行比较。 当比较图像时,在候选药剂存在下孵育的胚胎硬骨鱼的截断鳍的形态变化与在不存在候选药物的情况下提出的胚胎硬骨鱼的截肢鳍相比表明候选试剂影响再生。
    • 3. 发明申请
    • USE OF FISH LARVAE AS A SCREENING MODEL
    • 使用鱼类幼虫作为筛选模型
    • WO2004044241A2
    • 2004-05-27
    • PCT/EP2003/012706
    • 2003-11-13
    • DEVELOGEN AKTIENGESELLSCHAFT FÜR ENTWICKLUNGSBIOLOGISCHE FORSCHUNGAUSTEN, Matthias
    • AUSTEN, Matthias
    • C12Q1/68
    • G01N33/52G01N33/5088G01N2333/4603
    • This present invention concerns the use of fish larvae, in particular zebrafish larvae or medaka larvae, as a model organism for investigating metabolism diseases, such as obesity and associated diseases, as well as for the development of corresponding prevention and/or treatment strategies. This present invention concerns, in particular, a procedure for the identification and/or characterization of genes and/or gene products or active substances which affect energy homeostasis as well as a pharmaceutical composition comprising genes, gene products or active substances identified by using the procedure in accordance with this present invention for the prevention and/or treatment of diseases, in particular metabolism diseases, such as obesity, and other diseases concerning the regulation of body weight as well as associated diseases, such as eating disorders, cachexia, diabetes mellitus, high blood pressure, coronary heart disease, hypercholesterolemia, dyslipidemia, osteoarthritis, gallstone disorders, cancer, such as, for example, cancer of the genital organs, and sleep apnea. Furthermore, this present invention concerns a procedure for determining the fat content of fish larvae, in particular of zebrafish larvae or medaka larvae.
    • 本发明涉及鱼类幼虫,特别是斑马鱼幼虫或青la幼虫作为研究代谢疾病(例如肥胖症和相关疾病)的模型生物的用途,以及用于开发相应的 预防和/或治疗策略。 本发明特别涉及用于鉴定和/或表征影响能量稳态的基因和/或基因产物或活性物质的方法以及包含通过使用该方法鉴定的基因,基因产物或活性物质的药物组合物 根据本发明用于预防和/或治疗疾病,特别是代谢性疾病如肥胖症,以及其它有关调节体重的疾病以及相关的疾病,如进食障碍,恶病质,糖尿病, 高血压,冠心病,高胆固醇血症,血脂异常,骨关节炎,胆结石病症,癌症,例如生殖器官癌症和睡眠呼吸暂停。 此外,本发明涉及确定鱼幼体,特别是斑马鱼幼虫或青la幼虫脂肪含量的方法。
    • 7. 发明申请
    • USE OF FISH LARVAE AS A SCREENING MODEL
    • 作为筛选模型的鱼类LARVAE的使用
    • WO2004044241A3
    • 2004-09-10
    • PCT/EP0312706
    • 2003-11-13
    • DEVELOGEN AGAUSTEN MATTHIAS
    • AUSTEN MATTHIAS
    • G01N33/50G01N33/52C12Q1/68
    • G01N33/52G01N33/5088G01N2333/4603
    • This present invention concerns the use of fish larvae, in particular zebrafish larvae or medaka larvae, as a model organism for investigating metabolism diseases, such as obesity and associated diseases, as well as for the development of corresponding prevention and/or treatment strategies. This present invention concerns, in particular, a procedure for the identification and/or characterization of genes and/or gene products or active substances which affect energy homeostasis as well as a pharmaceutical composition comprising genes, gene products or active substances identified by using the procedure in accordance with this present invention for the prevention and/or treatment of diseases, in particular metabolism diseases, such as obesity, and other diseases concerning the regulation of body weight as well as associated diseases, such as eating disorders, cachexia, diabetes mellitus, high blood pressure, coronary heart disease, hypercholesterolemia, dyslipidemia, osteoarthritis, gallstone disorders, cancer, such as, for example, cancer of the genital organs, and sleep apnea. Furthermore, this present invention concerns a procedure for determining the fat content of fish larvae, in particular of zebrafish larvae or medaka larvae.
    • 本发明涉及鱼类幼虫,特别是斑马鱼幼虫或楝树幼虫作为模型生物体用于研究代谢疾病如肥胖症和相关疾病以及发展相应的预防和/或治疗策略的用途。 本发明特别涉及用于鉴定和/或表征影响能量稳态的基因和/或基因产物或活性物质的方法,以及包含通过使用该程序鉴定的基因,基因产物或活性物质的药物组合物 根据本发明,用于预防和/或治疗疾病,特别是代谢疾病,例如肥胖症和其它与体重调节有关的疾病以及相关疾病,如进食障碍,恶病质,糖尿病, 高血压,冠心病,高胆固醇血症,血脂异常,骨关节炎,胆结石病,癌症,例如生殖器官的癌症和​​睡眠呼吸暂停。 此外,本发明涉及用于测定鱼幼虫,特别是斑马鱼幼虫或稚贝幼虫的脂肪含量的方法。